Calvin J. Meaney PharmD

Calvin Meaney

Calvin J. Meaney
PharmD

Contact Information
312 Kapoor Hall
Buffalo, NY 14214
Phone: 716-645-2826
Fax: 716-829-6093
cjmeaney@buffalo.edu



Professional Summary:

Dr. Meaney is a clinical pharmacist-scientist in the field of nephrology. His clinical practice is at the Erie County Medical Center, the Regional Center of Excellence in Transplantation in Kidney Care. He serves on two acute care medical teams: (1) Nephrology Consultation Service and (2) Internal Medicine where he precepts pharmacy students and residents.

Dr. Meaney‘s research is focused on the optimization of drug therapy through the application of quantitative clinical pharmacology. He leads a multidisciplinary group of researchers to address novel personalization of erythropoiesis-stimulating agents in hemodialysis patients. Other work has focused on drug-induced nephrotoxicity where he was one of the first researchers to identify vancomycin and piperacillin/tazobactam as a nephrotoxic combination.

In the classroom, Dr. Meaney strives to excite and engage students through real-world application of pharmacotherapy using active learning techniques. He finds the personal interaction with students through advising and mentoring to be the most rewarding part of being a faculty member.

Education and Training:

  • Fellowship, Immunosuppressive Pharmacology, University at Buffalo School of Pharmacy and Pharmaceutical Sciences (2014)
  • Residency, Pharmacy, University of Maryland Medical Center (2012)
  • PharmD, Pharmacy, State University of New York at Buffalo (2011)

Employment:

  • Clinical Assistant Professor, Pharmacy Practice, State University of New York at Buffalo, School of Pharmacy and Pharmaceutical Sciences (2014-present)

Awards and Honors:

  • Phi Lambda Sigma, University at Buffalo Chapter Alumni of the Year (2016)
  • Rho Chi Teaching Excellence Award (2015)
  • American College of Clinical Pharmacy, Immunology/Transplantation Practice and Research Network Travel Award (2013)
  • Teva Pharmaceuticals Certificate of Achievement in the Study of Pharmacy (2011)
  • Grace W. Capen Award for Academic Excellence (2007)


Journal Articles:

See all (2 more)

Professional Memberships:

  • American Association of Colleges of Pharmacy (2014–present)
  • American Society of Nephrology (2013–present)
  • American Society of Transplantation (2013–present)
  • American Society for Clinical Pharmacology and Therapeutics (2012–2015)
  • American Society of Health-System Pharmacists (2009–2013)
  • American College of Clinical Pharmacy (2009–present)

Presentations:

  • "Definition and validation of a novel metric to assess erythropoiesis stimulating agent response in hemodialysis patients." American Society of Nephrology 2017 Kidney Week (2017)
  • "Increased risk of acute kidney injury in critically ill children treated with vancomycin and piperacillin/tazobactam" American College of Clinical Pharmacy 2017 Annual Meeting (2017)
  • "Systematic review of erythropoiesis-stimulating agent dosing algorithms in hemodialysis patients" American College of Clinical Pharmacy, 2017 Annual Meeting (2017)
  • "Association of vancomycin trough concentration with response to treatment for acute pulmonary exacerbation of cystic fibrosis" Pediatric Pharmacy Advocacy Group (PPAG) (2017)
  • "Vancomycin vs. vancomycin-rifampin for the treatment of MRSA-associated acute pulmonary exacerbations of cystic fibrosis" Pediatric Pharmacy Advocacy Group (PPAG) (2017)
  • "Influence of sex and race on mycophenolic acid pharmacokinetics in stable African American and Caucasian renal transplant recipients" American Society of Clinical Pharmacology and Therapeutics 2016 Annual Meeting (2016)
  • "Drug-Induced Renal Disease" WNYSHP Spring Meeting, Western New York Society of Health-System Pharmacists, NA (2016)
  • "Sex and ABCB1 haplotype associations with tacrolimus pharmacokinetics in renal transplant recipients." American Society of Nephrology 2015 Kidney Week, American Society of Nephrology (2015)
  • "Sex and race influences on tacrolimus pharmacokinetics in renal transplant recipients." American Society of Nephrology 2015 Kidney Week, American Society of Nephrology (2015)
  • "ABCB1 haplotypes, sex, calcineurin inhibitors, and lipid profiles post-renal transplant" American Transplant Congress 2015 (2015)
  • "Differences in mycophenolic acid and metabolite, mycophenolic acid glucuronide exposures between calcineurin inhibitor regimens post-renal transplant" American Society for Clinical Pharmacology and Therapeutics 2015 Annual Meeting (2015)
  • "Sex and ABCB1 haplotype associations with tacrolimus pharmacokinetics in renal transplant recipients." American Society of Nephrology 2015 Kidney Week, American Society of Nephrology (2015)
  • "Comparison of Mycophenolic Acid Exposure and Gastrointestinal Adverse Effects in Stable Renal Transplant Recipients: Association to Calcineurin Inhibitor Therapy" American Society of Nephrology 2014 Kidney Week, American Society of Nephrology (2014)
  • "Influences of Sex and Calcineurin Inhibitors on Mycophenolic Acid Pharmacokinetics Post-Renal Transplant" World Transplant Congress 2014, American Transplant Society (2014)
  • "Leukocyte Patterns and Mycophenolic Acid Pharmacokinetics in African American and Caucasian Renal Transplant Recipients" World Transplant Congress 2014, American Transplant Society (2014)
  • "New Dyslipidemia and Hypertension Guidelines: Impact on the Kidney Disease Patient" ACPE Accredited CE, Kappa Psi, Buffalo Graduate Chapter (2014)
  • "Influence of ABCC2 Haplotype and Calcineurin Inhibitors on Mycophenolic Acid Pharmacokinetics in Stable Renal Transplant Recipients" American Society for Clinical Pharmacology and Therapeutics 2014 Annual Meeting, American Society for Clinical Pharmacology and Therapeutics (2014)
  • "Development of an Immunosuppressive Adverse Effects Index: Validity and Reliability Evaluation." American Society of Nephrology 2013 Kidney Week, American Society of Nephrology (2013)
  • "Sex and Haplotype Associations with Adverse Effects of Calcineurin Inhibitors Post-Renal Transplant" American Society for Clinical Pharmacology and Therapeutics 2013 Annual Meeting, American Society for Clinical Pharmacology and Therapeutics (2013)
  • "Intravenous Lipid Emulsion for Amlodipine Overdose" Critical Care Congress 2012, Society for Critical Care Medicine (2013)
  • "Therapeutic Drug Monitoring of Mycophenolic Acid – Is Ignorance Truly Bliss?" ACPE Accredited CE, University of Maryland School of Pharmacy (2012)
  • "Incidence of Vancomycin Associated Nephrotoxicity among Adult Internal Medicine Patients" The University Health Consortium Conference, UHC (2011)
  • "Simvastatin Prescribing Practices Prior to Product Labeling Changes" American Society of Health-System Pharmacists Midyear Clinical Meeting 2011, ASHP (2011)
See all (13 more)

Service Activities:

  • Institutional Review Board; Voting Member of the University at Buffalo IRB; Committee Member (2016–present)
  • UBSPPS Admissions Commitee; Committee Member (2016–present)
  • UBSPPS Clinical Research Program; Co-Director (2016–present)
  • UBSPPS Experiential Education Faculty Advisory Committee; Committee Member (2016–present)
  • Operation Heart Wellness Clinic; Served as a pharmacist preceptor for students providing community education and service within the American Heart Association Operation Heart Wellness Clinic.; Teacher (2016)
  • American Journal of Nephrology; Ad Hoc Reviewer (2016–present)
  • UBSPPS Pharmacotherapeutics Committee; Committee Member (2015–present)
  • Drug Enforcement Agency Drug Disposal Program; Served as a pharmacist preceptor to pharmacy interns completing the DEA Drug Disposal Program.; Teacher (2015–2016)
  • Pharmacotherapy; Ad Hoc Reviewer (2015–present)
  • American Journal of Transplantation; Ad Hoc Reviewer (2013–present)

School News:

In the Media:


Clinical Specialties:

Clinical Offices:

Insurance Accepted:



Contact Information

312 Kapoor Hall
Buffalo, NY 14214
Phone: 716-645-2826
Fax: 716-829-6093
cjmeaney@buffalo.edu